AIHead and Neck Squamous Cell Carcinomaimmunotherapy
Harnessing Cancer-Testis Antigens for Precision Immunotherapy in Head and Neck Cancer
By MedXY|Oct 24, 2025
This study identifies specific cancer-testis antigens (CTAs) as promising targets for personalized immunotherapy in head and neck squamous cell carcinoma (HNSCC), validated across multiomic datasets to enhance therapeutic precision.
